Quick Answer
RetinalGenix Technologies Inc. reported Research And Development Expense of $373.3 thousand for the year ending 2024.
- RetinalGenix Technologies Inc. showed a decrease of -28.8% in Research And Development Expense from 2023 to 2024.
- This data is from RetinalGenix Technologies Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2020 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2020 to 2024), RetinalGenix Technologies Inc.'s Research And Development Expense has declined by 13.5%.
- Historical annual values: Fiscal year 2024: $373.3 thousand | Fiscal year 2023: $524.2 thousand | Fiscal year 2021: $680.3 thousand | Fiscal year 2020: $431.6 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: